PharmaNet Development Group, Inc. Experts to Showcase Bioanalytical Posters at ASMS 2011

PRINCETON, N.J., May 23, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, announced today that its experts will be sharing a range of innovative bioanalysis solutions, including high resolution mass spectrometry applications, at the ASMS 59th Conference on Mass Spectrometry and Allied Topics in Denver, Colorado from June 5 to June 9. PharmaNet's scientists welcome you to attend their poster sessions throughout the conference.

Tuesday June 7


Poster 255:On-Cartridge Derivatization for the Determination of Bisphosphonates in Human Urine

Authors: Nicolas Jean, Sylvain Lachance, Nadine Boudreau, Sofi Gagnon-Carignan, Ann Levesque


Poster 277: Stability issues and method development of a polar phenolic quaternary amine compound in human plasma by LC/MS/MS

Authors: Valerie Montminy, Nicolas Piquet, Sylvain Lachance, Nadine Boudreau; Ann Levesque


Poster 257: Using ICP-MS Detection for Determination of Bismuth in Human Blood and Plasma Samples

Authors: Nadia Savard, Sebastien Gagne, Francois Viel, Brigitte Pellerin, Nadine Boudreau


Poster 258: High Throughput Analysis of Biological Samples Containing Trace Metals with Limited Down Time by ICP-MS

Authors: Sebastien Gagne, Francois Viel, Nadine Boudreau, Sylvain Lachance, Sofi Gagnon-Carignan, Ann Levesque


Poster 267: Development and Validation of a Dried Blood Spot Assay for the Determination of Midazolam in Human Whole Blood by LC/MS/MS

Authors: Guy Havard, Marie-Claude Theberge, Nadine Boudreau, Ann Levesque


Poster 273: Ultra Low Picograms Determination of a Glucocorticoid in Human Plasma

Authors: Nadia Smith, Nicolas Jean, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann Levesque


Poster 272: An Ultrasensitive LC/MS/MS Method for the Determination of Formoterol in Human Plasma at Femtogram Level

Authors: Isabelle M. Levesque, Francois Viel, Sylvain Lachance, Nadine Boudreau, Ann Levesque


Poster 271: Evaluation of Hemolysis Effect during Sample Collection and Handling to Mimic Incurred Samples during LC/MS/MS Method Validation

Authors: Sebastien Gagne, Sylvain Lachance, Nadine Boudreau, Ann Levesque


Poster 268: Analyte and Internal Standard Cross Signal Contributions in Mass Spectrometric Detection and Their Impact on the Quantitation by LC/MS

Authors: Aimin Tan, Isabelle A. Levesque, Isabelle M. Levesque, Francois Viel, Nadine Boudreau, Ann Levesque


Poster 269: A Novel Automated LC/MS/MS Method for the Simultaneous Determination of Levothyroxine (T4) and Liothyronine (T3) in Human Serum

Authors:Gilles Provencher, Francois Viel, Nadine Boudreau, Ann Levesque


Poster 270: LC/MS/MS Analysis of Doxercalciferol and its Main Metabilite in Human Plasma at Low Picogram Level

Authors: Guy Havard, Sylvain Lachance, Nadine Boudreau, Ann Levesque


Wednesday June 8


Poster 146: A Robust and Selective Method for Two Omega-3 Fatty Acids (Eicosapentanoic Acid and Docosahexaenoic Acid) in Several Matrix Species

Authors: Guy Havard, Nathalie Pelletier, Sylvain Lachance, Nadine Boudreau, Ann Levesque, Farhad Amiri, Bruno Battistini, Tina Sampalis


Thursday June 9


Poster 469: Determination of Polypeptides and other Large Molecular Weight Molecules by LC/MS/MS

Authors: Genevieve Emond, Nadia Savard, Simon Bedard, Philippe Belanger, Nancy Lampron, Nathalie Pelletier, Marie-Josee Marcoux, Sylvain Lachance, Nadine Boudreau, Ann Levesque



About PharmaNet

PharmaNet Development Group, Inc., a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.

Contact: Anne-Marie Hess
Phone: (609) 951-6842
E-mail: ahess@pharmanet.com

SOURCE PharmaNet Development Group, Inc.

Back to news